Skip to main content
Features
Assistant
AI grounded in research
Search
Full-text citation search
Collections
Organize and monitor papers
All Features →
Integrations
MCP
Connect AI agents to Scite
API
Programmatic data access
Holdings
Full-text via your library
Zotero Plugin
Citation data in Zotero
Browser Extension
Citation badges anywhere
All Integrations →
Data
Rankings
Pricing
Log In
Start Free Trial
Features
Assistant
AI grounded in research
Search
Full-text citation search
Collections
Organize and monitor papers
All Features →
Integrations
MCP
Connect AI agents to Scite
API
Programmatic data access
Holdings
Full-text via your library
Zotero Plugin
Citation data in Zotero
Browser Extension
Citation badges anywhere
All Integrations →
Data
Rankings
Pricing
Log In
Start Free Trial
Taiki Isei
Sign up to set email alerts
96
Publications
1,114
Citation Statements Received
4,236
Citation Statements Given
How they've been cited
1,147
38
1,063
13
How they cite others
2,838
58
4,159
19
Affiliations
Osaka Medical Center for Cancer and Cardiovascular Diseases
,
Kansai Medical University
Publications
Order By: Most citations
Anti-PD1 checkpoint inhibitor therapy in acral melanoma: a multicenter study of 193 Japanese patients
Nakamura
1
,
Namikawa
2
,
Yoshino
3
et al.
2020
Annals of Oncology
Abstract
Show
148
10
147
3
Get access via publisher
Add to collection
Cite
Cytokine biomarkers to predict antitumor responses to nivolumab suggested in a phase 2 study for advanced melanoma
Yamazaki
1
,
Kiyohara
2
,
Uhara
3
et al.
2017
Cancer Science
Abstract
Show
137
6
127
8
Get access via publisher
Add to collection
Cite
Efficacy comparison between anti-PD-1 antibody monotherapy and anti-PD-1 plus anti-CTLA-4 combination therapy as first-line immunotherapy for advanced acral melanoma: A retrospective, multicenter study of 254 Japanese patients
Nakamura
1
,
Namikawa
2
,
Kiniwa
3
et al.
2022
European Journal of Cancer
48
2
76
1
Get access via publisher
Add to collection
Cite
The wound/burn guidelines – 6: Guidelines for the management of burns
Yoshino
1
,
Ohtsuka
2
,
Kawaguchi
3
et al.
2016
The Journal of Dermatology
Abstract
Show
77
0
68
0
Get access via publisher
Add to collection
Cite
Anti-PD-1 antibody monotherapy versus anti-PD-1 plus anti-CTLA-4 combination therapy as first-line immunotherapy in unresectable or metastatic mucosal melanoma: a retrospective, multicenter study of 329 Japanese cases (JMAC study)
Nakamura
1
,
Namikawa
2
,
Yoshikawa
3
et al.
2021
ESMO Open
Abstract
Show
60
5
59
0
Get access via publisher
Add to collection
Cite
Sweat-gland carcinoma with neuroendocrine differentiation (SCAND): a clinicopathologic study of 13 cases with genetic analysis
Goto
1
,
Kukita
2
,
Honma
3
et al.
2022
Modern Pathology
36
5
58
0
Get access via publisher
Add to collection
Cite
Real-world efficacy of anti-PD-1 antibody or combined anti-PD-1 plus anti-CTLA-4 antibodies, with or without radiotherapy, in advanced mucosal melanoma patients: A retrospective, multicenter study
Umeda
1
,
Yoshikawa
2
,
Kiniwa
3
et al.
2021
European Journal of Cancer
45
1
46
0
Get access via publisher
Add to collection
Cite
Systemic therapy for Asian patients with advanced
BRAF V600
‐mutant melanoma in a real‐world setting: A multi‐center retrospective study in Japan (
B‐CHECK‐RWD
study)
Namikawa
1
,
Ito
2
,
Yoshikawa
3
et al.
2023
Cancer Medicine
Abstract
Show
27
2
34
0
Get access via publisher
Add to collection
Cite
1
2
3
4
5
6